Literature DB >> 16311366

Expression of HIF-1 alpha in human tumours.

A Jubb, K Hillan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311366      PMCID: PMC1770802     

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  Expression of HIF-1alpha in human tumours.

Authors:  P J van Diest; M M Vleugel; E van der Wall
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

Authors:  J Torhorst; C Bucher; J Kononen; P Haas; M Zuber; O R Köchli; F Mross; H Dieterich; H Moch; M Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Authors:  A M Jubb; T Q Pham; A M Hanby; G D Frantz; F V Peale; T D Wu; H W Koeppen; K J Hillan
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

4.  Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.

Authors:  Yusuke Mizukami; Jingnan Li; Xiaobo Zhang; Michael A Zimmer; Othon Iliopoulos; Daniel C Chung
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

  4 in total
  2 in total

1.  Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.

Authors:  Mingjun Guo; Chengkui Cai; Guangyi Zhao; Xiuchun Qiu; Haien Zhao; Qiong Ma; Liying Tian; Xuelian Li; Yunsheng Hu; Bo Liao; Baoan Ma; Qingyu Fan
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

2.  Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

Authors:  Changwei Dou; Zhenyu Zhou; Qiuran Xu; Zhikui Liu; Yuqun Zeng; Yufeng Wang; Qing Li; Liang Wang; Wei Yang; Qingguang Liu; Kangsheng Tu
Journal:  Oncogene       Date:  2018-09-24       Impact factor: 8.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.